# Pizarra — PT-pseudo_11345b8a7ab3 (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_11345b8a7ab3
Task: 1

Encounter: Urology - outpatient on 04 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 67-year-old male
  - PSA: 113.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 2.61 ng/mL²
  - PSA velocity: 13.27 ng/mL/yr
  - Prior PSA: 108.5 ng/mL
  - Prostate volume: 43.0 mL
  - Months since last PSA: 1
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.94776064 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension, Osteoarthritis
  - Problem list / PMHx: Hypertension, Osteoarthritis
  - Current medication: amlodipine, valsartan, lisinopril, metoprolol, paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 113 ng/mL. PI-RADS 5. PSAD 2.61. Prostate volume 43 mL. DRE nodus. csPCa 0.95.

Vitals: weight 86 kg, height 174 cm, BMI 28.4, BP 138/88 mmHg, HR 70 bpm. Smoking: Non-smoker.

Chief complaint: Persistent PSA elevation combined with previously confirmed high-grade disease on biopsy.

History: Aged 67, this non-smoker works as a primary school teacher. Marriage and residence in an independent retirement community define his current lifestyle. Initial prostate investigation occurred three years back, with his adult son acting as the designated contact. Lower urinary tract symptoms sit at a moderate IPSS score of 12. Hypertension and osteoarthritis are managed via amlodipine, valsartan, lisinopril, metoprolol, and paracetamol PRN. Daily 45-minute walks characterize his routine, alongside a weekly alcohol intake of roughly 13 units. Memory clinic screening yielded normal results, and he reports stable cognition. A knee arthroscopy for degenerative joint disease took place five years ago; major abdominal surgeries are absent. Unexplained weight loss and bone pain are denied.

Physical examination: DRE: A firm, irregular nodule is distinctly palpable within the right posterior peripheral zone, while the rest of the gland remains symmetrically enlarged and non-tender. Vital parameters show a blood pressure of 138/88 mmHg and a heart rate of 70 bpm. Systemic inspection detects no lymphadenopathy or hepatosplenomegaly.

Patient info: primary school teacher; Married; Lives in retirement community (independent unit).
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 13 units / week; exercise Walking 45 min/day; IPSS score: 12/35 (moderate LUTS).

Recent other appointments: Memory clinic — baseline screening.
Admin: Interpreter: not required. Consent for data use: signed.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: NO BIOPSY
  p(biopsy = yes) = 0.47 +/- 0.26   (95% CI 0.04-0.94)

Where the uncertainty comes from:
  - aleatoric  dA = 0.25  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.07  (few labelled cases resemble this one)
  - 1.0 effective neighbours out of 10; 1 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {no}

TIER 'discuss': A +/- dA straddles 0.5. The classifier genuinely CANNOT tell these two answers apart; measured accuracy in this tier is 0.61, barely above the 0.62 majority-class rate. Its number is a starting point only, and the case must be decided on the clinical evidence retrieved by the other participants.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=5.0, bx_ord=3.0, psa=113.0, age=67.0, psad=2.61, dre_ord=1.0, vol=43.0, n_pmhx=2.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
  The statistical recommender relied only on the structured panel. It could not weigh the high PSA velocity (13.27 ng/mL/yr) and the very high csPCa predicted probability (0.94776064), which strongly suggest aggressive disease, against the PI-RADS 5 score and the prior positive biopsy status. It also missed the context provided by the DRE finding ("Nodus") and the specific details from the retrieved documents, such as the full mpMRI report or the PSA history trend.

WHY THE SUGGESTION COULD BE WRONG
  The prior suggests 'NO BIOPSY' with a wide interval (0.47 +/- 0.26), indicating high uncertainty. This uncertainty is likely due to the contradiction between the high csPCa probability (0.95) and the prior positive biopsy status. If the prior positive biopsy is definitive, the question shifts from "does he have cancer" to "is the current high PSA due to recurrence or another cause?" The wide interval suggests the panel is highly ambiguous regarding the next step.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
  <document> radiology / mpMRI report -> If the report contradicts the PI-RADS 5 or suggests a different lesion, it would challenge the current risk assessment.
  <document> PSA history (trend) -> If the trend shows a rapid, concerning rise, it would increase the urgency for further investigation.
  <document> previous GP / urology consultation notes -> These notes might clarify the clinical context or the reason for the re-evaluation.
  <document> laboratory panel -> This could provide context on other markers that might influence the interpretation of the PSA/PSAD.

## [4] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
  One block per document you opened. Quote the values and phrases that matter, verbatim and with units. Numbers, lesion descriptions, dates, explicit radiologist or clinician recommendations. Do not paraphrase a number. If a document turned out to be uninformative, say so in one line - that is an honest result.
  
  **radiology / mpMRI report**
  {"case_id": "PT-pseudo_11345b8a7ab3", "radiology_report": "Subject: Multiparametric MRI of the Prostate\nFacility: Amsterdam UMC, VUmc location\nDate: 03 February 2025\n\nClinical context: Follow-up assessment prompted by a PSA reading of 113.0 ng/mL and a previously positive biopsy.\n\nASSESSMENT: Prostate volume registers at 43.0 mL. T2-weighted sequences highlight a sharply demarcated, profoundly hypointense focus within the right posterior peripheral zone at mid-gland, spanning 18 x 14 x 12 mm. Diffusion-weighted imaging confirms marked restriction, mirrored by corresponding hypointensity on ADC maps. Dynamic contrast studies show prompt, intense focal uptake compared to adjacent tissue. Extraprostatic extension remains absent. Seminal vesicle invasion is not observed. Lymph node enlargement is conspicuous only by its absence.\n\nIMPRESSION: PI-RADS 5 lesion in the right posterior peripheral zone. Prostate volume 43.0 mL yielding a PSA density of 2.61 ng/mL/mL. csPCa predicted probability 0.94776064."}
  
  **psa_trend**
  {"case_id": "PT-pseudo_11345b8a7ab3", "psa_trend": [{"date": "Nov 2022", "val": 12.0}, {"date": "Aug 2023", "val": 5.2}, {"date": "May 2024", "val": 17.3}, {"date": "Feb 2025", "val": 113.0}]}
  
  **previous_notes**
  {"case_id": "PT-pseudo_11345b8a7ab3", "previous_notes": [{"date": "09 Jun 2024", "author": "Dr. C. Peters (GP)", "text": "A PSA reading of 108.5 ng/mL was documented in May 2024, showing a steady upward trajectory. He notes escalating lower urinary tract symptoms alongside pervasive fatigue. The case was transferred to the urology outpatient clinic for thorough evaluation."}]}
  
  **laboratory_results**
  {"case_id": "PT-pseudo_11345b8a7ab3", "laboratory_results": [{"name": "PSA", "val": "113.0 ng/mL", "date": "18 Jan 2025", "flag": "H"}, {"name": "Free PSA", "val": "18.15 ng/mL", "date": "18 Jan 2025", "flag": ""}, {"name": "%Free PSA", "val": "16%", "date": "18 Jan 2025", "flag": "L"}, {"name": "Haemoglobin", "val": "15.3 g/dL", "date": "18 Jan 2025", "flag": ""}, {"name": "WBC", "val": "7.2 x10^9/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Platelets", "val": "317 x10^9/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Creatinine", "val": "72 umol/L", "date": "18 Jan 2025", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "18 Jan 2025", "flag": ""}, {"name": "Testosterone", "val": "14.3 nmol/L", "date": "18 Jan 2025", "flag": ""}, {"name": "Alkaline phosphatase", "val": "74 U/L", "date": "18 Jan 2025", "flag": ""}, {"name": "LDH", "val": "181 U/L", "date": "18 Jan 2025", "flag": ""}, {"name": "HbA1c", "val": "6.5 %", "date": "18 Jan 2025", "flag": ""}]}

NOT RETRIEVED
  get_family_history: Not called because the retrieval economy suggests it is not necessary for the immediate decision based on the other retrieved data.

WHAT THE EVIDENCE SUPPORTS
  FOR sampling this patient now:
  - PI-RADS 5 lesion in the right posterior peripheral zone
  - PSA velocity of 13.27 ng/mL/yr
  - csPCa predicted probability of 0.94776064
  - Prior biopsy was positive
  
  AGAINST sampling this patient now:
  - Prior biopsy was positive (suggesting current PSA elevation might be recurrence)

WHERE THIS LEANS
  The retrieved evidence strongly points towards aggressive disease, evidenced by the PI-RADS 5 score, high PSA velocity, and a very high csPCa predicted probability. This contradicts the statistical prior's suggestion of 'NO BIOPSY' by providing strong clinical evidence for aggressive pathology.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [5] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [6] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

Given the prior positive biopsy, the decision hinges on whether the current findings warrant re-biopsy. The evidence strongly supports sampling due to a PI-RADS 5 lesion, a high PSA velocity of 13.27 ng/mL/yr, and a csPCa predicted probability of 0.94776064. This aggressive profile, despite the prior positive result, mandates further tissue assessment to guide management.

Variables that carried weight: bx=decisive, dre=noted, psa=decisive, vol=important, psad=important, cspca=important, pirads=decisive
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
